Erratum to: PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells

Lei Qi,Keishirou Amano,Eiichi Azuma,Kentaro Kihira,Hidemi Toyoda,Hiroki Hori,Naoto Sakurai,Dong-Qing Xu,Yoshihiro Komada,Ye Zhou

doi:10.1186/s12935-015-0261-6

Lei Qi, Keishirou Amano + Show 8 more

Open Access

https://doi.org/10.1186/s12935-015-0261-6

Copy DOI

Abstract

[This corrects the article DOI: 10.1186/s12935-015-0239-4.].

Highlights

The original version of this article [1] contained an error
*Correspondence: chylae2003@hotmail.com; komada@clin.medic.mie‐u.ac.jp 1 Department of Pediatrics and Developmental Science, Mie University Graduate School of Medicine, 2‐174 Edobashi, Tsu, Mie 514‐8507, Japan Full list of author information is available at the end of the article withdrawal of MK-2206
LAN-1 and LAN-1-MK were treated with/ without MK-2206 (5 μM) in RPMI1640 with 10 % FBS for 12 h followed by analysis of cell cycle phase distribution, as introduced in “Methods”

Summary

Introduction

The original version of this article [1] contained an error. After publication it came to the authors’ attention that the figure legends were displayed incorrectly. Erratum to: PDK1‐mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells Lei Qi1,2*, Hidemi Toyoda1, Dong‐qing Xu1,2, Ye Zhou3, Naoto Sakurai1, Keishirou Amano1, Kentaro Kihira1, Hiroki Hori1, Eiichi Azuma1 and Yoshihiro Komada1* The original version of this article [1] contained an error.

Results

Conclusion